SEC Tracker
Get the app

Alaunos Therapeutics TCRT

858,789 shares of Common Stock held by Reporting Persons

Ownership stake disclosure by Fairmount Funds Management LLC

Form
Schedule 13D
Filed
Importance
Notable
  1. 858,789 shares of Common Stock held by Reporting Persons
  2. Aggregate purchase price of $100,199,073.47
  3. 19.99% ownership in Alaunos Therapeutics
  4. Includes 171,000 shares from Series C Preferred Stock conversion

Written from the Schedule 13D on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Alaunos Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. BioCardia BCDA public float $10M, Jun 30, 2025
  2. Raphael Pharmaceutical RAPH public float $9M, Jun 30, 2025
  3. Traws Pharma ONTX public float $10M, Jun 30, 2025
  4. Mannatech MTEX public float $10M, Jun 30, 2025
  5. Bioxytran BIXT public float $9M, Jun 30, 2025